268 related articles for article (PubMed ID: 12572870)
1. Intestinal microflora as a therapeutic target in inflammatory bowel disease.
Mitsuyama K; Toyonaga A; Sata M
J Gastroenterol; 2002 Nov; 37 Suppl 14():73-7. PubMed ID: 12572870
[TBL] [Abstract][Full Text] [Related]
2. [Probiotics and prebiotics for the treatment of inflammatory bowel disease].
Mitsuyama K
Nihon Rinsho; 2005 May; 63(5):850-8. PubMed ID: 15881181
[TBL] [Abstract][Full Text] [Related]
3. Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials.
Hedin C; Whelan K; Lindsay JO
Proc Nutr Soc; 2007 Aug; 66(3):307-15. PubMed ID: 17637082
[TBL] [Abstract][Full Text] [Related]
4. Clinical usefulness of probiotics in inflammatory bowel diseases.
Mach T
J Physiol Pharmacol; 2006 Nov; 57 Suppl 9():23-33. PubMed ID: 17242485
[TBL] [Abstract][Full Text] [Related]
5. Gut microflora: a new target for therapeutic approaches in inflammatory bowel disease.
Mitsuyama K; Sata M
Expert Opin Ther Targets; 2008 Mar; 12(3):301-12. PubMed ID: 18269340
[TBL] [Abstract][Full Text] [Related]
6. [Role of intestinal flora in inflammatory bowel disease and probiotics place in their management].
Belkahla N; Maamouri N; Ouerghi H; Ben Ammar A
Tunis Med; 2005 Mar; 83(3):132-6. PubMed ID: 15929439
[TBL] [Abstract][Full Text] [Related]
7. Side Effects Associated with Probiotic Use in Adult Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Dore MP; Bibbò S; Fresi G; Bassotti G; Pes GM
Nutrients; 2019 Dec; 11(12):. PubMed ID: 31810233
[TBL] [Abstract][Full Text] [Related]
8. Clinical utility of probiotics in inflammatory bowel disease.
Cain AM; Karpa KD
Altern Ther Health Med; 2011; 17(1):72-9. PubMed ID: 21614946
[TBL] [Abstract][Full Text] [Related]
9. Probiotics for the treatment of inflammatory bowel disease.
Veerappan GR; Betteridge J; Young PE
Curr Gastroenterol Rep; 2012 Aug; 14(4):324-33. PubMed ID: 22581276
[TBL] [Abstract][Full Text] [Related]
10. Probiotics in the treatment of human inflammatory bowel diseases: update 2011.
Meijer BJ; Dieleman LA
J Clin Gastroenterol; 2011 Nov; 45 Suppl():S139-44. PubMed ID: 21992953
[TBL] [Abstract][Full Text] [Related]
11. Probiotics and IBD.
De Greef E; Vandenplas Y; Hauser B; Devreker T; Veereman-Wauters G
Acta Gastroenterol Belg; 2013 Mar; 76(1):15-9. PubMed ID: 23650777
[TBL] [Abstract][Full Text] [Related]
12. Antibiotics and probiotics in inflammatory bowel disease: why, when, and how.
Prantera C; Scribano ML
Curr Opin Gastroenterol; 2009 Jul; 25(4):329-33. PubMed ID: 19444096
[TBL] [Abstract][Full Text] [Related]
13. Probiotics for inflammatory bowel diseases: a promising adjuvant treatment.
Coqueiro AY; Raizel R; Bonvini A; Tirapegui J; Rogero MM
Int J Food Sci Nutr; 2019 Feb; 70(1):20-29. PubMed ID: 29804478
[TBL] [Abstract][Full Text] [Related]
14. Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease.
Conte MP; Schippa S; Zamboni I; Penta M; Chiarini F; Seganti L; Osborn J; Falconieri P; Borrelli O; Cucchiara S
Gut; 2006 Dec; 55(12):1760-7. PubMed ID: 16648155
[TBL] [Abstract][Full Text] [Related]
15. [Crohn disease, ulcerative colitis. When bacteria attack the intestinal wall....].
Duchmann R; Lochs H; Kruis W
MMW Fortschr Med; 1999 Dec; 141(51-52):48-51. PubMed ID: 10949626
[TBL] [Abstract][Full Text] [Related]
16. Modulating the microbiota in inflammatory bowel diseases: prebiotics, probiotics or faecal transplantation?
Verbeke KA; Boesmans L; Boets E
Proc Nutr Soc; 2014 Nov; 73(4):490-7. PubMed ID: 24969143
[TBL] [Abstract][Full Text] [Related]
17. The therapeutic impact of manipulating microbiota in inflammatory bowel disease.
Kanauchi O; Mitsuyama K; Andoh A
Curr Pharm Des; 2009; 15(18):2074-86. PubMed ID: 19519445
[TBL] [Abstract][Full Text] [Related]
18. Is there any place for alimentary probiotics, prebiotics or synbiotics, for patients with inflammatory bowel disease?
Seksik P; Dray X; Sokol H; Marteau P
Mol Nutr Food Res; 2008 Aug; 52(8):906-12. PubMed ID: 18384087
[TBL] [Abstract][Full Text] [Related]
19. Mucosal barrier, bacteria and inflammatory bowel disease: possibilities for therapy.
Merga Y; Campbell BJ; Rhodes JM
Dig Dis; 2014; 32(4):475-83. PubMed ID: 24969297
[TBL] [Abstract][Full Text] [Related]
20. From gut microflora imbalance to mycobacteria infection: is there a relationship with chronic intestinal inflammatory diseases?
Tomasello G; Bellavia M; Palumbo VD; Gioviale MC; Damiani P; Lo Monte AI
Ann Ital Chir; 2011; 82(5):361-8. PubMed ID: 21988043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
